RDguru: A Conversational Intelligent Agent for Rare Diseases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39298307.
- Also identified by DOI 10.1109/JBHI.2024.3464555.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Large language models (LLMs) hold significant promise in clinical practice, yet their real-world adoption is constrained by their propensity to produce erroneous and occasionally harmful outputs, particularly in the intricate domain of rare diseases (RDs). This study introduces RDguru, a conversational intelligent agent leveraging the LangChain framework and powered by GPT-3.5-turbo. RDguru offers a comprehensive suite of functionalities, encompassing evidence-traceable knowledge Q&A and professional medical consultations for differential diagnosis (DDX), integrating authoritative knowledge sources and reliable tools. A novel multi-source fusion diagnostic model, rooted in deep Q-network, amalgamates three diagnostic recommendation strategies (GPT-4, PheLR, and phenotype matching) to enhance diagnostic recall during medical consultations. Through tailored tools and advanced algorithms for retrieval-augmented generation, RDguru excels in knowledge Q&A, automated phenotype annotation, and RD DDX. A multi-aspect Q&A analysis demonstrates RDguru outperforms ChatGPT in generating descriptions aligned with authoritative knowledge, quantified by ROUGE scores, GPT-4-based automatic rating, and RAGAs evaluation metrics. Testing on 238 published RD cases reveals that RDguru's top 5 multi-source fusion diagnoses recapture 63.87% of actual diagnoses, marking a 5.47% improvement over the state-of-the-art diagnostic method PheLR. Furthermore, RDguru's consultation strategy proves effective in eliciting diagnostically beneficial phenotypes and refining the prioritization of genuine diagnoses through multi-round phenotype-orient questioning. Evaluations against established benchmarks and real-world patient data demonstrate RDguru's efficacy and reliability, highlighting its potential to enhance clinical decision-making in the realm of RDs.
Medical subject headings
- Rare Diseases